Evidence map›Paper›PMID 40948727›Full record

ArticleCase reports in urology2025

Urofacial Syndrome, an Expressive and Unmasking Sign of Voiding Dysfunction: Case Report and Review of the Literature.

Fawaz Alkeraithe, Waleed Altulayqi, Mutasim Alkhalifah, Faisal Alasmari, Mohammad Asiri, Ahmad Alhazmi

Abstract readCase Reports
In one paragraph

Article in Case reports in urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Fawaz AlkeraitheDepartment of Urology, King Fahad Medical City, Riyadh, Saudi Arabia.ORCID https://orcid.org/0000-0003-2113-8183
Waleed AltulayqiDepartment of Urology, King Fahad Medical City, Riyadh, Saudi Arabia.ORCID https://orcid.org/0009-0005-9361-7644
Mutasim AlkhalifahDepartment of Urology, King Fahad Medical City, Riyadh, Saudi Arabia.ORCID https://orcid.org/0000-0001-7768-5835
Faisal AlasmariDepartment of Urology, King Fahad Medical City, Riyadh, Saudi Arabia.ORCID https://orcid.org/0000-0003-0657-9220
Mohammad AsiriDepartment of Urology, King Fahad Medical City, Riyadh, Saudi Arabia.ORCID https://orcid.org/0000-0001-8219-9268
Ahmad AlhazmiDepartment of Urology, King Fahad Medical City, Riyadh, Saudi Arabia.ORCID https://orcid.org/0000-0002-2778-2829

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Urofacial syndrome (UFS) is a rare autosomal recessive disorder characterized by voiding dysfunction, inverted facial expressions when smiling, and potential mutations in LRIG2 or HPSE2 genes. We report two sisters diagnosed with UFS who were managed using sacral neuromodulation (SNM). The first, aged 24, had recurrent UTIs, chronic urinary retention, and a trabeculated bladder without vesicoureteral reflux (VUR). Genetic testing identified a homozygous LRIG2 variant. Following SNM, her voiding function improved, reducing the frequency of catheterization. The second patient, aged 27, presented with a Grade 5 left-sided VUR, severe hydronephrosis, and a nonfunctioning left kidney. Urodynamic studies revealed an acontractile bladder. Post-SNM, her postvoid residual decreased to 30 mL, allowing independent voiding. Both displayed the hallmark inverted facial grimace. Diagnostic imaging and urodynamics confirmed neurogenic bladder, excluding spinal anomalies. Management included clean intermittent catheterization (CIC) and SNM, which enhanced bladder emptying and reduced catheter dependence. This case highlights SNM as a promising therapeutic option in UFS, improving voiding efficiency and quality of life. Early recognition of the distinctive facial expression is critical to prevent upper tract damage. Urologists should suspect UFS in patients with voiding dysfunction and abnormal facial expressions, considering SNM as a viable intervention. Further studies on SNM's role in UFS are warranted.

Indexed as

dysfunctionfacialinvertedneuromodulationOchoasacral

Identifiers

PMID40948727
PMCPMC12431806

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.